PROFESSIONAL EDITION

The largest community of pharma leaders

Platelet BioGenesis Augments Board of Directors with Oncology and Immunotherapy Industry Leader Richard Murray, Ph.D.

CAMBRIDGE, Mass.–(BUSINESS WIRE)–#BoD–Richard Murray, Ph.D., President and CEO of Jounce Therapeutics, Joins Platelet BioGenesis Board of Directors…

 

 

 

http://www.businesswire.com/news/home/20190604005211/en/Platelet-BioGenesis-Augments-Board-Directors-Oncology-Immunotherapy/

Recent Articles